CVE:MIR

Medmira Inc (MIR.V)

0.06
-0.00 (0.00%)
as of Jun 3, 2026, 1:30:00 pm Market Open.
8 watching
0
premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK
In Canada, this smallcap (C$210 million) biotech in Halifax submitted its antibody test to the FDA. Since April 22, MedMira has soared from 6 cents/share to over 30. There's scant coverage or even stock metrics to report. Also MedMira is one of many companies to submit such tests to the FDA, but it's worth keeping on your radar. At this stage of pandemic, I wouldn't rule out any stock that could effectively fight the virus.
DON'T BUY
Got approval from FDA, but sales are not following through. Running out of cash. Any new financing could dilute stock price further.
BUY
Getting global acceptance of products. Low volume
Showing 1 to 3 of 3 entries
  • «
  • 1
  • »

Medmira Inc (MIR.V) Frequently Asked Questions

What is Medmira Inc stock symbol?

Medmira Inc is a Canadian stock, trading under the symbol MIR.V (previously MIR-X on Stockchase) on the TSX Venture Exchange (MIR-CV). It is usually referred to as TSXV:MIR or MIR.V

Is Medmira Inc a buy or a sell?

In the last year, there was no coverage of Medmira Inc published on Stockchase.

Is Medmira Inc a good investment or a top pick?

Medmira Inc was recommended as a Top Pick by Bruce Sellery on 2000-10-30. Read the latest stock experts ratings for Medmira Inc.

Why is Medmira Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Medmira Inc worth watching?

0 stock analysts on Stockchase covered Medmira Inc in the last year. It is a trending stock that is worth watching.

What is Medmira Inc stock price?

On 2026-06-03, Medmira Inc (MIR.V) stock closed at a price of $0.06.